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HIV-1 subtype C (HIV-1C) CXCR4-using virus is isolated infrequently and is poorly characterized.
Understanding HIV-1C env characteristics has implications for the clinical use of antiretrovirals that
target viral entry. A total of 209 env clones derived from 10 samples with mixed CCR5-(R5), CXCR4-
using (X4) or dual-tropic HIV-1C were phenotyped for coreceptor usage. Intra-patient X4 and R5
variants generally formed distinct monophyletic phylogenetic clusters. X4 compared to R5 envs had
signiﬁcantly greater amino acid variability and insertions, higher net positive charge, fewer glycosyla-
tion sites and increased basic amino acid substitutions in the GPGQ crown. Basic amino acid
substitution and/or insertion prior to the crown are highly sensitive characteristics for predicting X4
viruses. Chimeric env functional studies suggest that the V3 loop is necessary but often not sufﬁcient to
impart CXCR4 utilization. Our studies provide insights into the unique genotypic characteristics of X4
variants in HIV-1C.
& 2012 Elsevier Inc. All rights reserved.Introductions
Human immunodeﬁciency virus type-1 (HIV-1) envelope (env)
mediates viral entry by interacting with the primary receptor (CD4)
and a coreceptor (CCR5 or CXCR4) on target cells (Choe et al., 1996,
2003; Feng et al., 1996; Maddon et al., 1986; McDougal et al., 1986;
Shioda et al.,1991). HIV transmission predominantly occurs with
CCR5-using viruses (R5), and cross-sectional studies show that 70–
80% of patients with early-stage disease continue to harbor only R5
variants. In contrast, with advanced disease nearly half of patients
have dual/mixed (DM) viruses containing both R5 and variants that
can either utilize both coreceptors (dual) and/or CXCR4 using HIV-1
(X4), and only a few patients harbor purely X4 virus even in
advanced disease (Melby et al., 2006). The presence of DM or X4
virus is an independent risk factor for accelerated disease progression
(Japour et al., 1994; Koot et al., 1993; Richman and Bozzette, 1994).
Most of our current understanding of env interactions with the
host cell coreceptor is based on studies on subtype B viruses (HIV-1B).
However, the majority of infections worldwide are due to HIV-1ll rights reserved.
rtment of Medicine, Division
oston, MA 02118-2518, USA.subtype C (HIV-1C) (Osmanov et al., 2002; UNAIDS, 2009). Earlier
studies of subtype C infected individuals showed a predominance of
R5 viruses regardless of disease stage, suggesting that unique HIV-1C
env characteristics potentially limit the emergence of CXCR4-using
viruses (Abebe et al., 1999; Bjorndal et al., 1999; Cecilia et al., 2000).
However, a recent study from our group showed that around 15% of
approximately 150 women in Botswana with advanced disease
harbored CXCR4-using viruses (Lin et al., 2011), conﬁrming more
recent ﬁndings among other smaller HIV-1C cohorts (Cilliers et al.,
2003; Connell et al., 2008; Johnston et al., 2003; Michler et al., 2008;
Papathanasopoulos et al., 2002; Tien et al., 1999; Tscherning et al.,
1998; van Rensburg et al., 2002; Zhang et al., 1996). The small
number of CXCR4-using HIV-1C viruses studied to-date has limited
the understanding of the determinants of HIV-1 C env coreceptor
usage. Previous studies were also limited by the analysis of consensus
or population-based viral sequences and comparison of R5 and X4
sequences isolated from different individuals. More precise character-
ization of the genotypic determinants of HIV-1C coreceptor usage can
be achieved by analyzing co-circulating viral clones that have
different coreceptor usage (as determined by phenotypic assay),
which has been reported for only a few HIV-1C isolates (Zhang
et al., 2010). Such analyses are necessary to improve the accuracy of
genotypic algorithms for predicting coreceptor usage of HIV-1C
(Jensen et al., 2006). This is a high priority because CCR5 antagonists
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and CCR5 antagonists are being considered as prophylaxis against
HIV-1 transmission (Osmanov et al., 2002). Predicting coreceptor
usage by an accurate, timely, and cost-effective test will be important
as more infected individuals in developing countries are considered
for starting or switching to a CCR5 antagonist. In the current study we
performed an in-depth genotypic and phenotypic analysis of clonal
HIV-1C envelopes and present data which better deﬁne the genotypic
characteristics of CXCR4-using HIV-1C.Results
Co-receptor usage of clonal envelopes from DM HIV-1C viruses
We previously determined that 22 of 148 individuals HIV-1C-
infected women harbored DM viruses; none harbored exclusively
X4 virus (Lin et al., 2011). In the current study we examined 10
DM samples from 9 of those subjects; 6 samples were obtained
prior to ART and 4 samples were collected after virologic failure
on ART (Table 1). These samples were selected based on relatively
high levels of CXCR4 usage determined by the phenotypic assay.
The CD4 cell count level between DM samples which were used in
this study (median 201 cells/mm3, range 43–375) and the ones
not used for further clonal analysis (median 128.5 cells/mm3,
range 5–201) were not signiﬁcantly different (p¼0.050) suggest-
ing that we did not exclude subjects with less progressive disease
and potentially recent coreceptor switching. Env sequences were
also isolated from an additional 7 subjects harboring exclusively
R5 virus (Table 1). The R5 samples, selected based on high levels
of CCR5 usage detected by the coreceptor usage assay, tended to
be from women without ART exposure although viral levels and
CD4 counts were not signiﬁcantly different compared to DM
samples. We isolated a median of 18 env clones (range 11–36)
from each sample. Env clones that yielded an infectious pseudo-
virus were subsequently sequenced. A total of 209 infectious env
clones were sequenced and phenotyped, with a similar number of
clones from R5 and DM samples (median 13 [range 7–19] and 12
[9–18] clones per sample, respectively) (Tables 2 and 3). Of the
123 clones isolated from DM samples, 64 were R5, 39 were dual-
tropic, and 20 were X4. The proportion of R5 (median 52.8%Table 1
Clinical characteristics of study participants infected with HIV-1C.
Sample
ID
Population
tropism
Age cART
Exposure
CD4 counta
(cells/uL)
Viral loada
(copies/mL)
Infant
infected
8 DM 29 N 43 522,000 N
146 DM 29 N 172 653,000 Y
159 DM 33 N 116 154,000 N
192 DM 43 N 92 121,000 Y
202 DM 31 N 147 273,056 N
263 DM 29 N 201 230,000 N
172 DM 30 Y 309 1060 N
173 DM 25 Y 316 1290 Y
268 DM 23 Y 375 333,000 Y
269 DM N/A Y 319 10,600 N
19 R5 37 N 5 399,000 N
20 R5 37 N 83 67,600 N
77 R5 21 N 123 112,000 N
115 R5 40 N 180 741,000 N
149 R5 35 N 65 4690 N
161 R5 34 N 50 8550 N
170 R5 30 N 165 227,000 N
a Values at or closest to time of sample collection.[range 0–92%]), X4 (median 72.2% [range 0–94%]), and dual-tropic
(median 26.1% [range 0–97%]) viruses varied between subjects
(Fig. 1). Additionally, 86 env clones were obtained from the
7 subjects infected with R5 virus; all of these clones were
conﬁrmed as R5 by phenotyping. A neighbor-joining (NJ) tree of
all 164 full-length envs and reference sequences of different
subtypes obtained from the Los Alamos National Laboratory
(LANL) HIV database conﬁrmed that all isolates were subtype C
with bootstrap values 490% (data not shown). Envs from each
subject clustered together arguing against any sample contam-
ination or mislabeling.Phylogenetic relationship of co-circulating R5 and X4 envs
Env sequences obtained from different subjects but with the
same coreceptor phenotype did not cluster together, suggesting
that intra-subject envs shared greater genotypic similarity than
inter-subject envs that used the same coreceptor. Maximum
likelihood phylogenies showed that in 7 of the 10 DM samples
(DM8, DM146, DM159, DM192, DM263, DM268, and DM269), R5
and CXCR4-using env sequences clustered separately; the segre-
gation was supported with high bootstrap values (Z75%)
(Fig. 2A). One individual had two samples collected: DM202
was collected prior to ART whereas DM269 was collected at
virological failure after 44 months of ART (Fig. 2B). Samples from
both the time-points yielded only R5 and dual-tropic pseudo-
viruses. Separate clustering of the R5 and dual-tropic envs was
evident in the post-ART but not the pre-ART sequences. The
Slatkin–Maddison test, which assesses compartmentalization
(i.e. restriction of gene ﬂow) between two populations based on
the topology of the phylogenetic trees (Nickle et al., 2003), further
conﬁrmed the separation of intra-subject CXCR4 using and R5
sequences. In DM146, DM159, DM263, DM268, and DM269,
separating X4 and R5 sequences required more than 3 steps in
greater than 95% of the 1000 randomly generated trees, suggest-
ing signiﬁcant compartmentalization between envs with different
coreceptor usage (po0.05). Within the same ﬁve samples, the
mean R5-to-X4 pairwise maximum composite likelihood dis-
tances were signiﬁcantly greater than between co-circulating
CXCR4-using or R5 sequences (po0.01). The Slatkin–Maddison
and pairwise-distance analyses could not be performed in 2 sam-
ples (DM8 and DM192) because only one CXCR4-using env clone
was isolated. In DM172 and DM173, which contained no R5
sequences, there was no phylogenetic separation between X4 and
dual-tropic clones by ML tree bootstrap support value, Slatkin–
Maddison test, and distance comparisons (Fig. 2C). In general,
phylogenetic analyses showed that intra-subject R5 sequences
clustered independently from X4 envs, whereas dual-tropic envs
were often intermixed with either X4 or R5 viruses.
Divergence of co-circulating R5 and CXCR4-using sequences
from the calculated most recent common ancestor (MRCA) (Fig. 2,
asterisk) was used to estimate intra-subject evolution. In samples
with more than one of either CXCR4-using or R5 clones, the
median distance from the MRCA was greater for the CXCR4-using
rather than for the R5 sequences (po0.05, Wilcoxon rank sum
test), except in DM268 (p¼0.35). There were also no signiﬁcant
differences in distance from MRCA between X4 and dual-tropic
sequences in DM172 and DM173. All the generated MRCA env
sequences had the typical HIV-1C R5 V3 crown motifs of GPGQ
with no substitutions, except for in DM8 and DM173 (Table 2).
The predominance of the R5 V3 loop crown GPGQ motif and the
greater distances of CXCR4-using sequences from the predicted
MRCA support the observation that R5 viruses predominate early
after infection, and CXCR4-utilizing variants typically emerge
later in disease.
Table 2
HIV-1C V3 sequence characteristics.
ID Pheno-
type
# of
clones
V3 loopa V3
length
Net
charge
N-
glyco
11/25
Prediction
C-PSSM
prediction
Change in
GPGQb
DM8 MRCA CTRPGNNTGRSVRIGPRKAFYTTRKIIGDIRAAHC
R5 10 ——————R—————GQ———GE———————— 35 4 1 R5 X4 0
R5 1 ——————R—————GQ———GE———V———— 35 4 1 R5 X4 0
X4 1 —————————————LRT—————————— 34 7 1 X4 X4 1
DM146 MRCA CTRPDNNTRRSVRMGIGPGQVFYTNDIIGDIRQAHC
Dual 8 ————————R———————T———————R——— 36 5 1 X4 X4 0
R5 5 —————————————————————R——— 34 4 1 R5 X4 0
R5 2 ————————————————————————— 34 3 1 R5 X4 0
R5 1 ——————————————————————Y—— 34 2 1 R5 X4 0
R5 1 —————————————A——————————— 34 3 1 R5 X4 0
R5 1 —I———————I———————A—————E—S— 34 1 1 R5 X4 0
DM159 MRCA CTRPNNNTRKSVRIGPGQTFYATGEIIGDIRRAHC
R5 2 –I——————R—M————ALFT———N—Q——— 35 5 1 R5 X4 0
R5 2 –I——————R—M————AYFT———N—Q——— 35 5 1 R5 X4 0
R5 1 —————————————————————————— 35 5 1 R5 R5 0
Dual 1 ———I—RERK————RA—FR—QMT———Q—S— 35 6 0 R5 X4 1
Dual 1 ———I—RERK————RA—FR—QMT———Q—S— 35 5 0 R5 X4 1
X4 1 ———I—RERK————RA—FR—QMT———Q—S— 35 5 0 X4 X4 1
X4 1 ———I—RERK————RA—FR—QMT———Q—S— 35 6 0 X4 X4 1
X4 1 ———I—NVRN————RALFK—KMT———Q—S— 35 6 0 X4 X4 1
DM173 MRCA CVRPNNNTRKSVRIGIGRGQTFYANRIIGDIRQAHC
Dual 6 ——————————————————————————— 36 7 1 R5 X4 6
X4 3 ——————————————————————————— 36 7 1 R5 X4 3
DM172 MRCA CIRPGNNTRRRVRMGIGPGQTFYATGNIIGDIRQAHC
Dual 6 —M————————————————————————— 37 6 1 X4 X4 0
Dual 1 ——————————————————————————— 37 6 1 X4 X4 0
X4 1 ——————————————————————————— 37 6 1 X4 X4 0
X4 1 —M————————————————————————— 37 6 1 X4 X4 0
DM192 MRCA CTRPNNNTSQSIRIGPGQTFYAMGRIIGDIRQAHC
R5 5 —————————————————————————— 35 4 2 X4 X4 0
R5 1 ——————————————Y——————————— 35 4 2 X4 X4 0
R5 1 ——————RE———————Y——D———————— 35 2 1 R5 R5 0
R5 1 ——————RE———————Y——D———————— 35 2 1 R5 R5 0
Dual 1 —————RRK—————————I—GV—————Y— 35 5 0 R5 X4 0
DM202 MRCA CTRPGNNTSRSIRIGPGQTFYATGRITGNIRQAHC
R5 1 —I—————————————————V—D——L—— 35 5 2 X4 X4 0
R5 3 ————————————————————D————— 35 5 2 X4 X4 0
R5 1 —I—————————————————V—D————— 35 6 2 X4 X4 0
Dual 2 —I—————————————————V—D————— 35 5 2 X4 X4 0
Dual 1 —M————K——————R—————V—D——K—— 35 8 1 X4 X4 1
Dual 1 —M————R——————R—————V—D——K—— 35 8 1 X4 X4 1
Dual 1 —M————K——————R—————V—D————— 35 7 1 X4 X4 1
DM263 MRCA CIRPGNNTRKSMRIGPGQTFYATGDIIGDIRKAHC
R5 3 —————————————————————————— 37 5 1 R5 R5 0
R5 3 ——————————————————E———————— 37 5 1 R5 R5 0
R5 1 —T———————————————————N—Q——— 37 5 1 R5 R5 0
Dual 1 ——————————————————E———————— 37 5 1 R5 R5 0
Dual 1 ————K——————I—H—————K———————— 37 9 1 X4 X4 1
Dual 1 ————K——————I—H—————K———————— 37 9 1 X4 X4 1
Dual 1 ————K——————I—H—————K———————— 37 9 1 X4 X4 1
DM268 MRCA CTRPSNNTRRRVRIGIGPGQAFDATGEIIGDIRQAHC
X4 11 ————————————R——————Q——————— 37 6 1 X4 X4 11
R5 5 ————————S————YT—————————— 35 4 1 R5 R5 0
R5 2 ————————S————YT—————————— 35 4 1 R5 R5 0
DM269 MRCA CIRPGNNTSRSIRIGPGQAFYATGRIVGDIRQAHC
R5 10 —————————————T———————————— 35 5 2 X4 X4 0
R5 1 —————————————————————————— 35 5 2 X4 X4 0
Dual 6 —M————K——————RT———K————K——— 35 8 1 X4 X4 6
a V3 crow n motif in bold.
b Number of clones with substitution in GPGQ crow n.
N.H. Lin et al. / Virology 433 (2012) 296–307298X4, dual-tropic, and R5 sequences have unique characteristics
Intra-subject pairwise genetic distances between R5 sequences
isolated from the seven subjects with strictly R5 virus (median
0.0096 [range 0.0007–0.016]) were signiﬁcantly lower comparedto the genetic diversity observed among R5 envs isolated from
women with DM viruses (median 0.03 [range 0.007–0.05];
p¼0.05, 2-tail unpaired t-test). Similarly, the R5 V3 loops cloned
from each woman with exclusively R5 virus had lower mean site-
speciﬁc Shannon Entropy scores compared to R5 viruses cloned
Table 3
Concordance of genotypic methods in determining HIV-1C phenotype.
Phenotype of enva No. of sequences 11/25 Rule %correct C-PSSM %correct GPGQ substitution
and/or insertionc
%correct
DM samples
X4 20 16 80.0 20 100.0 20 100
Unique X4 V3b 7 6 85.7 7 100.0 7 100
Dual 39 30 76.9 38 97.4 35 89.7
Unique Dual V3b 13 9 69.2 12 92.3 10 76.9
X4þDual 59 46 78.0 58 98.3 55 93.2
Unique (X4þDual) V3b 20 15 75.0 19 95.0 17 85.0
R5 64 42 65.6 18 28.1 64 100
Unique R5 V3b 23 15 65.2 7 30.4 23 100
R5 samples
R5 86 86 100 78 90.7 86 100
Unique R5 V3b 20 20 100 19 95.0 20 100
ALL samples
ALL R5 150 128 85.3 96 64.0 150 100
ALL unique R5 V3b 43 35 81.4 26 60.5 43 100
a Coreceptor usage phenotype determined for each clonal env sequence.
b Unique V3 loop sequences of corresponding phenotype.
c GPGQ substitution and/or insertion around crown predicts CXCR4-usage, absence of both predicts R5 virus.
0%
20%
40%
60%
80%
100%
8 146 159 192 263 268 202 269 172 173
sample ID
R5 X4 Dual
Fig. 1. Composition of clones from dual/mixed (DM) env populations. Individual
sample identiﬁcation number are on the x-axis while the y-axis shows the
percentage of CCR5 using (R5), exclusive CXCR4 utilizing (X4), and dual-tropic
strains (dual).
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0.31 [0–1.23], respectively), but this difference was not statisti-
cally signiﬁcant (p¼0.2). The inter-subject amino acid entropy
was signiﬁcantly lower among R5 V3 loops (median 0 [range
0–1.08]) as compared to X4 (median 0.42 [range 0–1.025]) or
dual-tropic (median 0.32 [range 0–1.669]) V3 loops (p¼0.03 for
each comparison, Wilcoxon rank sum test) (Fig. 3). The GPGQ
crown motif was completely conserved in all the isolated R5
sequences (entropy of 0) with no insertions around the crown,
while X4 and dual-tropic sequences had much greater variability
(median entropy 0.5 and 0.69, respectively) and frequent sub-
stitutions around the motif. Interestingly, R5 sequences showed
increased variability outside of the V3 loop in the region between
C3–C5 (median entropy of 0.262 and 0.236 for clones isolated
from R5 and DM samples, respectively) compared to the X4
(median 0, po0.001) and dual-tropic (median 0, p¼0.03)
sequences, which were highly conserved.
None of the 204 full-length env sequences were identical
although several intra-patient sequences had identical V3 loop
sequences. Because the number of clones isolated from eachsubject varied, only unique V3 loop sequences were used for
analyses to identify distinct HIV-1C X4 env characteristics. A total
of 7 unique X4, 13 unique dual-tropic, and 43 unique R5 V3 loop
sequences were compiled from all the clones (Table 3). There was
no signiﬁcant difference in the median length of V3 loops
between the unique X4 and R5 sequences (median 36 amino
acids (aa) [range 34–37] versus 35 aa [34–36]; p¼0.10). The net
V3 loop charge was signiﬁcantly higher among X4 (medianþ6
[range 6–7]) and dual-tropic viruses (þ6 [range 5–10]) as
compared to R5 viruses (þ5 [range 2–6], both p-valueso0.0001)
sequences (Fig. 4). The R5 V3 loops had signiﬁcantly more
predicted N-linked glycosylation sites (PNGS) compared to the
X4 (p¼0.012) and dual-tropic (p¼0.025) sequences. Speciﬁcally,
all unique R5 sequences contained a PNGS at position 6 of the V3
loop. Only some of the unique X4 (5 of 7) and dual-tropic (10 of
13) variants contained a PNGS at position 6, and only 1 of the
CXCR4 using variants contained a PNGS at position 7 (Table 2).
Interestingly, 8 out of 43 R5 V3 sequences had a second PNGS at
position 7, which were all isolated from DM and not R5 quasis-
pecies (Fig. 3A and B).
One of the most distinctive properties of the unique CXCR4-
using V3 sequences was changes in and around the crown motif.
Among unique V3 loop sequences the GPGQ crown displayed an
arginine (R) or histidine (H) substitution in 71.4% of the unique X4
(n¼7) and 53.8% of dual-tropic envs (n¼13) but was conserved in
all the unique R5 sequences (n¼43) (Fig. 3 and Table 2). The two
X4 variants without any amino acid substitution in the GPGQ
crown, both isolated from DM172, instead possessed a GI amino
acid insertion prior to the crown. This insertion was observed in
45% of the unique X4/dual-tropic V3 loop sequences but was
absent in all of the R5 sequences. The prevalence of crown
substitutions in other HIV-1C sequences was further investigated
in CXCR4-using HIV-1C envs in the Los Alamos National Labora-
tories (LANL) HIV sequence database, which revealed a total of 42
unique X4 isolates. The coreceptor phenotype for these isolates
had been determined by various methods, including the MT2 cell
assay and assays using engineered cell lines, such as U87 and
Ghost cells. Thirty-seven of the 42 (88.1%) X4 sequences isolated
from 20 individual subjects had an R substitution at position 16
and/or R/H at position 18 within the V3 loop crown. Similar to our
observation, 4 of the 5 sequences contained a conserved GPGQ
crown, of which 3 V3s, isolated from the same patient, had
instead a GI insertion prior to the crown and one had an unusual
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R5               
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*
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*
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*
Fig. 2. Maximum likelihood (ML) tree analysis of co-circulating viral clones among dual/mixed (DM) env populations. Different shapes are used to represent the tropism of
individual env clones: square, R5 clones; triangle, X4 clones; and circle, dual-tropic clones. Asterisk (*) indicates predicted MRCA. Bootstrap values from 1000 replications
are shown at nodes and rooted to HXB2 env sequence. (A) ML phylogenies of clones isolated from the individuals in which CXCR4-using envs were segregated from R5
variants. (B) All clones are from the same individual but at different time points. Filled shapes indicate clones isolated from sample DM202, which was collected prior to
antiretroviral therapy (ART). Open shapes are clones isolated from sample DM269 after virological failure with ART. (C) Two samples (DM172 and DM173) from 2 separate
individual harbored only X4 and dual-tropic clones, which were closely related.
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Fig. 3. V3 loop sequences with the character and size of each logo representing the proportion of an amino acid at the speciﬁc site, and number based on position of
alignment with HXB2. The variability at each amino acid position was calculated using the Shannon entropy score and schematically represented by the number of
characters at each position, with a single character presenting 0 entropy score. R5 env sequences obtained from individuals infected with a population of exclusive R5
tropic (A) or DM (B) virus. Env sequences of X4 (C) and dual-tropic clones (B) isolated from individuals infected with a population of DM viruses. Asterisk (*) indicates
position of amino acid insertions. (A) R5 from R5 quasispecies, (B) R5 from DM quasispecies, (C) X4 from DM quasispecies and (D) Dual-tropic from DM quasispecies.
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Fig. 4. Greater V3 net charge in X4 and dual-tropic sequences compared to R5 env
sequences. Each dot represents the net charge of a unique env V3 loop sequence,
black lines are medians. x-Axis shows the env tropism, and y-axis displays the
calculated charge. P-values from 2-tailed Wilcoxon rank-sum test for pairwise
comparison are indicated.
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the LANL database that did not contain a positive amino acid
substitution in the GPGQ crown or surrounding region (Louwagie
et al., 1995; Trkola et al., 1998). In comparison, a search of
phenotyped HIV-1C R5 sequences in the LANL database yielded
a total of 148 sequences, all of which retained the GPGQ crown,
except one with an unusual RPGQ crown motif (accession no.
AF391249). Among 15 unique dual-tropic sequences in the
database, 9 had a substitution in the crown, 2 had a GI insertion,
and only 4 sequences retained the GPGQ crown without any
substitutions at the surrounding residues.
Performance of common genotypic predictive algorithms
The ability of commonly used algorithms, such as the 11/25 rule
and C-PSSM, to predict coreceptor usage based on the V3 sequence
was assessed (Table 3). The 11/25 rule was relatively sensitive in
predicting CXCR4 usage among X4 sequences, correctly predicting
X4 phenotype in 85.7% of unique sequences and 80% of all 20X4
N.H. Lin et al. / Virology 433 (2012) 296–307302clones, but with less accuracy in assessing dual-tropic and R5 V3
loop sequences. The 11/25 rule incorrectly predicted CXCR4 usage
for R5 clones isolated from 3 DM samples (DM192, 269 and 202)
because of the presence of an arginine at position 25 in the V3 loop.
In contrast, predictions made by the 11/25 rule were 100% con-
cordant with the phenotype for R5 clones isolated from a population
of entirely R5 viruses (86 clones, 20 unique V3).
We also evaluated the predictive value of C-PSSM, an algo-
rithm based on known HIV-1C env sequences and coreceptor
phenotype (Table 3). The C-PSSM accurately predicted CXCR4
usage for 100% of all unique X4, and 92% of unique dual-tropic
sequences (Table 3). In contrast, C-PSSM accurately predicted
CCR5 usage for only 61% of the 43 unique R5 sequences. This
decreased accuracy in predicting R5 phenotype was largely
inﬂuenced by R5 sequences isolated from DM samples with co-
circulating X4/dual-tropic viruses. Among R5 clones isolated from
samples that harbored exclusively R5 virus, the accuracy was 95%
among unique V3 loops. In contrast, among the 23 unique R5
sequences isolated from DM samples CCR5 usage was predicted
correctly in only 30%. In comparison to the C-PSSM and 11/25
rule, the presence of one of the two unique X4 V3 loop char-
acteristics we found, either an insertion prior to the crown or
substitutions in the GPGQ crown, was 100% predictive for CXCR4-
usage among the unique isolated X4 clones. Presence and absence
of these two features correctly predicted CXCR4 usage in 10 out of
13 (76.9%) unique dual-tropic and in all of the 43 (100%) unique
R5 sequences respectively, regardless of whether the env was
isolated from a DM or R5 sample.
Signature amino acids differences between R5 and X4/dual-tropic
viruses
Signiﬁcant amino acid differences between co-circulating
CXCR4-using and R5 sequences isolated from the same subject
were identiﬁed using VESPA. The 8 intra-subject comparisons
were then combined to identify signature env sequence differ-
ences across all patients. Although no consistent amino acid was
identiﬁed, the analysis showed that signature amino acid differ-
ences were concentrated in speciﬁc regions. The greatest amino
acid differences between R5 and X4/dual-tropic sequences were
found in the V3 loop region, with some differences in the post-V3
and V5 regions (Fig. 5). Although the V1–V2 region is thought to
play a role in determining coreceptor usage (Chohan et al., 2005;
Coetzer et al., 2007, 2006; Pollakis et al., 2001), abundant0
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Fig. 5. All env sequences were aligned, and V1–V2, V3, V4–V5 segments corresponding
intra-patient R5 and CXCR4-using clones were mapped relative to the HXB2 env num
threshold of 0 and comparison of R5 and CXCR4-using sequences from within each of th
and dual-tropic clones, were not included in the analysis.insertions and deletions in this region made alignment of these
segments difﬁcult and ambiguous, and thus, many V1–V2
sequences were omitted from this analysis.
Determinant of coreceptor usage encoded in V3.
Because amino acid differences between R5 and X4/dual-
tropic HIV-1C sequences were concentrated primarily in the V3
loop we exchanged V3 sequences among X4 and R5 clones to
examine if coreceptor usage in subtype C depends on the V3 loop.
We constructed chimeric viruses by swapping V3 sequences
between co-circulating R5 and X4/dual-tropic clones. Chimeric
envs were made from isolates from ﬁve subjects (Fig. 6A).
Exchange of the V3 loop resulted in 13 functional V3 chimeric
viruses. In all V3 chimeras, except for 8B-N-B and 159R-L-R, the
inserted V3 loop changed the coreceptor usage of the chimeric
env to the coreceptor phenotype of the parental V3 loop clone
(Fig. 6B). Interestingly, chimeras with V3 loops from original dual-
tropic envs were able to use CCR5 and CXCR4 in only one of the
four cases (146 A-C-A); two chimeras (159 V-L-V and 269 K-J-K)
could not be tested because they yielded env which did not
produce infectious pseudovirions, and the fourth chimera (159
R-L-R) in which V3 from a dual-tropic clone was inserted into an
X4 background yielded an X4 virus. Similarly, the chimeric 8 B-N-
B env, which carried a V3 loop from the X4 8N clone inserted into
the R5 8B env backbone, resulted in an R5 phenotype. Because
amino acid differences were also concentrated beyond V3, we
constructed a few V3–V5 chimeras. Insertion of the X4 V3–V5
region from 8N into the R5 8B env yielded a virus capable of
utilizing CXCR4. By contrast, insertion of the V3–V5 segment from
the 269J dual-tropic env into a 269 K R5 env resulted in an
envelope unable to use CXCR4 for cell entry. In one case, V3 loop
exchanges between envs from two different subjects resulted in
infectious viruses and a corresponding change in coreceptor
phenotype; the V3 loop from subject 268Y X4 env was inserted
into the 159 V R5 env and yielded a chimeric env that used the
CXCR4 receptor. Conversely, the 159 V R5 V3 loop inserted within
the 269Y X4 backbone resulted in an R5 phenotype.Discussion
To our knowledge this study is the largest and most compre-
hensive analysis of CXCR4-using HIV-1C envelope clones to date.C3 C4V4 V5
to HXB2 env amino acids were deﬁned. Signature amino acid differences between
bering. Signature amino acids were determined using the VESPA program with
e 8 subjects. Two DM samples which were not composed of R5 clones, with only X4
Clone ID Chimeric virus V3 chimeric V3-V5 chimeric
8B R5 8B-N-B R5 X4
8N X4 8N-B-N R5 R5
146A R5 146A-C-A Dual
146C Dual 146C-A-C R5
269J Dual 269J-K-J R5
269K R5 269K-J-K non-infectious R5
159V R5 159R-V-R R5
159R X4 159V-R-V X4
159L Dual 159R-L-R X4
159L-R-L X4
159L-V-L R5
159V-L-V N/A
159V-268Y-159V X4
268Y-159V-268Y R5
268M R5 268Y-M-Y R5
268Y X4 268M-Y-M non-infectious
 Chimeric virus could not be constructed
Phenotype of chimeric viruses of co-circulating R5 and X4 clones
Phenotype
 Chimeric virus with exchange of V3-V5 region of co-circulating virus of another phenotype
 Chimeric virus with exchange of V3 loop from co-circulating virus of another phenotype
Phenotype 
of isolate
V3 loop
R5
X4
R5-X4-R5
X4-R5-X4
Co-circulating
primary isolates
Chimeric viral clones
Fig. 6. Co-circulating viral clones with different coreceptor usage were used as
templates for the construction of chimeric env which contained segments of both
env. (A) Initially, V3 loop from a R5 env was swapped with a CXCR4-using env
using overlapping PCR method, and for some samples a larger region was
exchanged. (B) Phenotype of the chimeric envs determined on a phenotypic assay
using U87-CD4-CCR5 and U87-CD4-CXCR4 cells.
N.H. Lin et al. / Virology 433 (2012) 296–307 303We found that in general X4 envs are distinct from R5 variants,
while dual-tropic clones often share genetic features with the co-
circulating X4 and R5 HIV-1Cs. The majority of distinguishing
genotypic characteristics among X4 and R5 strains reside in the
env V3 loop. Speciﬁcally, all HIV-1C X4 variants had either a two
residue insertion prior to the V3 loop crown or basic amino acid
substitutions within the generally invariant GPGQ crown motif.
Similar to X4 variants of other HIV-1 subtypes, such as clade B, we
found that X4 V3 loops of HIV-1C have signiﬁcantly greater net
positive charge and loss of glycosylation sites compared to R5
clones (De Jong et al., 1992; Hoffman et al., 2002; Pollakis et al.,
2001). Our chimeric envelope data conﬁrmed that the HIV-1C V3
loop was the primary determinant for coreceptor usage, although
in some isolates env regions outside of V3 were also important for
conferring CXCR4 usage. Interestingly, we found that R5 clones
from subjects with DM viruses demonstrated greater diversity in
the V3 loop compared to R5 env sequences from individuals
harboring exclusively R5 viruses. This observation has potential
implications for understanding the relatively low rate of emer-
gence of CXCR4-using HIV-1C viruses.
We examined a large number of individual env clones
(n¼209) from 17 different samples with a DM or R5 phenotype
(Lin et al., 2011). This approach allowed us to compare both intra-
and inter-subject characteristics of X4, R5, and dual-tropic envs.
We found that HIV-1C DM viruses compromised varying propor-
tions of X4, R5, and dual-tropic sequences. This observation
contrasts with a previous study showing that R5 clones arecompletely absent among HIV-1C DM isolates (Singh et al.,
2009). However, in that earlier study env clones were isolated
from proviral DNA after in vitro passage of peripheral blood
mononuclear cells, which may have selected for X4 and dual-
tropic viruses (Singh et al., 2009). This study is also unique in that
most previous studies have compared HIV-1C envelopes of
differing coreceptor phenotypes isolated from different subjects
and used population-based sequencing strategies to determine
env sequences. We directly isolated virus sequences from plasma
and examined clonal sequences to overcome some of the limita-
tions inherent in these previous studies. Our intra- and inter-
subject comparisons also allowed us to demonstrate that in the
majority of cases X4 viruses are phylogenetically distinct from co-
circulating R5 strains, even though the diverse X4 variants did not
form a unique cluster when we examined viruses from different
subjects. On the other hand, dual-tropic strains clustered with
either co-circulating R5 or X4 strains in the intra-subject analyses.
Together, these observations suggest that as with other subtypes,
dual-tropic HIV-1C variants may be evolutionary intermediates
between R5 and X4 viruses.
Dual-tropic viruses likely emerge from R5 viruses, and addi-
tional selective mutations are required for conformational
changes in the coreceptor binding site that presumably increase
afﬁnity for CXCR4 while completely restricting binding to CCR5
coreceptor. It has been suggested that dual-tropic viruses have
more ﬂexibility in displaying different structural conﬁrmations
and binding sites that potentially can allow interactions with both
CCR5 and CXCR4 (Cardozo et al., 2007; Hartley et al., 2005; Nolan
et al., 2008). The genetic modiﬁcations in env that prevent CCR5
use and enhance CXCR4-usage likely result in the phylogenetic
separation of R5 and X4 variants within a subject. Future analysis
of longitudinal samples may provide additional insight into the
emergence and evolution of X4 viruses from dual-tropic and R5
strains.
Our sequence analysis also demonstrated that the V3 loop
contained the primary distinguishing features separating X4 and
R5 variants. Interestingly, although X4 and R5 envelope V3 loops
had distinctive signature motifs, the V3 sequences among
co-circulating viruses were still more closely related to each other
than to X4 and R5 variants, respectively, from different subjects.
Among all unique R5 sequences, the net V3 loop charge was
signiﬁcantly lower than X4 or dual-tropic sequences, which is
consistent with earlier observations in smaller numbers of iso-
lates (Coetzer et al., 2006; Johnston et al., 2003). Although we did
not ﬁnd any signiﬁcant differences between lengths of V3 loop we
did ﬁnd a signiﬁcant difference in the number of PNGS among R5
compared to X4 or dual-tropic V3 loops, with a conserved site at
position 6 among all R5 clones and in many a second prominent
glycosylation site. This glycosylation pattern may facilitate the
virus-CCR5 interaction (Pollakis et al., 2004, 2001; Polzer et al.,
2002). Similar glycosylation changes have been observed in the
subtype B and D comparisons between CXCR4-using and R5
variants (Clevestig et al., 2006; Fenyo et al., 1988; Huang et al.,
2007). We also found that positive amino acid substitutions or
two-amino acid insertions were highly speciﬁc for subtype C X4
virus, consistent with previous observations of crown substitution
at the 4th position with an R, Y, K or H amino acids in CXCR4-
using HIV-1C isolates (Abebe et al., 1999; Batra et al., 2000;
Bjorndal et al., 1999; Coetzer et al., 2006; Ping et al., 1999).
Interestingly, while crown substitutions and pre-crown insertions
were observed among the majority (90%) of X4 envs, these
characteristics were present in some but were not a necessary
and dominating characteristic of the isolated dual-tropic clones.
The crown motif forms the beta turn in the env secondary
structure, and basic amino acid substitutions or the two residue
insertion likely resulted in conformational changes that allow for
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2005; Hu et al., 2000; Pollakis et al., 2004; Suphaphiphat et al.,
2007). Besides changing coreceptor usage these V3 loop modiﬁca-
tions may also change V3 presentation and subsequently result in
differences in antibody reactivity against X4 versus R5 isolates.
Antibodies against the HIV-1C V3 domain are rarely elicited early
in infection (Bou-Habib et al., 1994; Li et al., 2006), and it remains
unclear if they appear with greater frequency against X4 variants,
potentially explaining the limited emergence of CXCR4 using
viruses during HIV-1C infection.
We further conﬁrmed the importance of the envelope V3 loop
as a determinant for coreceptor usage by constructing and
examining chimeric envelopes. Few previous studies have done
similar functional analyses to conﬁrm whether certain env
regions inﬂuence coreceptor usage among HIV-1C viruses. One
study constructed chimeric envelopes from a single subject
infected with HIV-1 subtype C and showed that the principal
determinant for coreceptor usage was in the V3 loop although
changes in the V4 regions were speculated as compensatory or
stabilizing mutations (Zhang et al., 2010). We observed that
sequences outside the V3 loop are likely involved in determining
coreceptor usage because some dual-tropic clones had identical
V3 loops as co-circulating R5 or X4 viruses. This ﬁnding may also
explain the inability of some previously described genotypic
methods to accurately predict coreceptor usage in all cases solely
based on V3 loop sequences. For example, some dual-tropic V3
loops from DM159, DM173, and DM263 were identical to the
related X4 or R5 variants. These ﬁndings also suggest that V3 loop
mutations that distinguish pure X4 and R5 variants are only
established after modiﬁcations outside the V3 loop that allow for
both CXCR4 and CCR5 usage among HIV-1C. Our chimeric
envelope constructions incorporating V3–V5 env regions conﬁrm
that non-V3 segments are often necessary elements in dictating
coreceptor usage among HIV-1C. Envelope V1–V2 loop modiﬁca-
tions potentially also contribute to coreceptor switching
(Hoffman et al., 2002; Labrosse et al., 2001), but we did not
examine this issue in our sequence or chimera analysis. Extensive
V1–V2 variability makes alignments and phylogenic interpreta-
tions unreliable. Our chimera studies clearly show that in the
majority of cases coreceptor usage is determined by the V3 loop.
Exchanging V3 loop segments between two different subjects
demonstrates that changes in the V3 loop can confer coreceptor
switching even when other portions of the envelope are not
highly homologous. Some sequences, such as DM8, require V3–V5
elements for changing coreceptor usage. And in subject DM269,
we were unable to generate a dual-tropic variant within a R5
envelope backbone suggesting that it may require other segments
beyond V3–V5, such as the V1–V2 loops.
Our large genotype-phenotype dataset allowed us to test the
accuracy of the two most commonly used genotypic methods for
determining coreceptor usage at a clonal level. Both C-PSSM and
the 11/25 rule had high sensitivity for predicting X4 usage among
HIV-1C CXCR4-using clones, but the algorithms were associated
with high false positive rates among co-circulating R5 clones.
False positive identiﬁcation of CXCR4-usage may have occurred
because the C-PSSM algorithm was based on a training set of 279
subtype C sequences derived predominantly from population
sequencing, and coreceptor usage phenotype was determined
using a variety of assays (Jensen et al., 2006). In addition, a
previous study using HIV-1C isolates from a similar population of
subjects from Botswana found that the 11/25 rule predicted
CXCR4 use only 39% of the time (Ndung’u et al., 2006). Sequences
in that study also were obtained by population sequencing and likely
failed to detect genotypic differences in minority CXCR4-using
species. These observations suggest that population sequences of
R5 and X4 variants may inadequately identify salient genotypicchanges necessary for CXCR4 usage in subtype C. Our analyses also
highlight the high prevalence of pre-crown insertions or basic amino
substitutions within the GPGQ motif speciﬁcally in X4 variants. This
genotype signature (basic amino acid insertion or substitution in the
GPGQ crown) was present in 41 of 42 unique HIV-1C X4 sequences
present in the LANL database. Unfortunately, this signature sequence
motif fails to detect CXCR4 usage in all dual-tropic strains, thus the
presence of this signature motif can only be used to exclude
candidates for CCR5 antagonist therapy in the absence of phenotypic
data. Identifying appropriate HIV-1C infected candidates for CCR5
inhibitors will still require improvement in the accuracy of genotypic
algorithms or phenotypic data.
Interestingly, we found that the 11/25 rule and C-PSSM
algorithm were better at predicting CCR5 usage in clones isolated
from subjects with exclusively R5 virus as opposed to clones
isolated from individuals with DM viruses. In addition, we found
that R5 clones from subjects with strictly R5 viruses had less env
amino acid variability compared to R5 envs from subjects with a
mixture of viruses using both the CCR5 and CXCR4 coreceptor. It
is possible that the selective pressures on a quasispecies with X4
variants affect co-circulating R5 viruses in ways which give them
less ‘‘typical’’ R5 features, leading to the poor performance of
genotypic algorithms. Differences in selective pressure may also
explain differences in diversity observed among R5 env sequences
isolated from subjects with R5 versus DM quasispecies. On the
other hand, CXCR4-using viruses in individuals with DM quasis-
pecies may emerge only after some threshold level of env
sequence variability is achieved in the infected host. Only long-
itudinal analysis can help determine whether HIV-1C CXCR4
emergence depends on a pre-existing level of env sequence
diversity or whether presence of dual-tropic and X4 viruses
generate more virus divergence.
This study had several limitations to consider. We did not
employ single genome ampliﬁcation (SGA), which may limit inter-
pretation of some of the results from the study because of possibility
of resampling and PCR-mediated recombination (Fang et al., 1998;
Liu et al., 1996; Meyerhans et al., 1990). The env genes were initially
ampliﬁed in an earlier study to determine the coreceptor usage (Lin
et al., 2011). We did employ PCR conditions to minimize founder
effects and recombination. Analyses of our env sequence datasets
using the Recombinant Identiﬁcation Program (RIP) (http://
www.hiv.lanl.gov) and Genetic Algorithm for Recombination Detec-
tion (GARD) (Kosakovsky Pond et al., 2006) suggest that some
isolated sequences could be recombinants although the programs
failed to identify a consistent breakpoint among all the clones within
a subject. It remains unclear, however, if potential recombination
occurred in vivo or during PCR ampliﬁcation. Failure to observe env
sequences which were phylogenetically in-between the X4 and R5
variants suggests that distinct clustering among the exclusively
CCR5 and CXCR4-using viruses was likely not an artifact of bulk
PCR, and in fact represent sequences circulating in vivo. We
potentially could have missed phylogenetically intermediate recom-
binant sequences because of limited sequence sampling during the
clonal analysis. However, a recent study comparing traditional PCR
cloning with SGA did not ﬁnd that one method was more biased
than the other in isolating certain species, and the level of diversity
of an HIV quasispecies obtained from both methods was similar
(Jordan et al., 2010). Even though this is one of the largest sets of env
clones with associated phenotypic data on coreceptor usage, we still
had a limited number of DM samples because of the small number
of HIV-1C individuals with CXCR4-using viruses. Lastly, the CXCR4-
using isolates in this study were not isolated at the initial time of
coreceptor switching, during which we could most likely identify
the minimal genetic changes necessary for CXCR4 usage. This was
not possible as this cohort study did not have such extensive
longitudinal samples.
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of coreceptor usage in HIV-1C, which has previously been
restricted by the small number of HIV-1C CXCR4-using isolates
available, and the heterogeneity of the sequence and phenotype
information. To our knowledge this is the ﬁrst study to decipher
the genetic determinants of CXCR4 usage in HIV-1C at a clonal
level, among co-circulating clones of different coreceptor pheno-
type, and in a large panel of subjects harboring DM and strictly R5
HIV-1C. The observations made in this study extend our current
knowledge about HIV-1C coreceptor usage, and provide one of the
largest datasets of env clonal sequence and corresponding corecep-
tor phenotype in HIV-1C isolates. Our ﬁndings are relevant for
effective therapeutics and coreceptor based prevention strategies
against the large and rapidly spreading HIV-1C epidemic.Materials and methods
Study subjects, cloning and phenotypic coreceptor testing
HIV-1 envelope clones were isolated from plasma from nine
women (ten different plasma samples) previously shown to
harbor DM virus and seven women harboring exclusively R5
virus (Lin et al., 2011). Samples were from selected women in the
Mashi study, which compared different strategies for prevention
of mother-to-child transmission in Botswana (clinicaltrials.gov
identiﬁer: NCT00197587) (Lockman et al., 2007; Thior et al.,
2006). The use of samples was approved by the institutional
review boards in both United States institutions (Harvard School
of Public Health and Partners Healthcare Systems) and by the
Botswana Ministry of Health.
Co-receptor usage was determined as previously described
(Lin et al., 2010). Brieﬂy, env amplicons were isolated from
plasma by pooling independent nested RT-PCR reactions. The
resulting amplicons were then cloned into the TOPO-TA vector
(Invitrogen). The CMV promoter was attached to individual full-
length env genes using overlapping PCR. Pseudotyped viruses
were generated by co-transfecting each env clone with the CMV
promoter and an env deﬁcient HIV-1 backbone (pNL4-3R-E-)
plasmid expressing luciferase. Coreceptor usage was determined
by assessing entry capacity in the presence and absence of a
coreceptor antagonist on U87 cells expressing CD4 and either
CXCR4 or CCR5.
Sequence analyses
Full-length bidirectional sequencing of env clones which pro-
duced viable virions for coreceptor determination was performed
using standard primers (Sanders-Buell andMcCutchan, 1995). All env
sequences will be deposited in Genbank (accession numbers pend-
ing). FindModel (http://www.hiv.lanl.gov) was employed to deter-
mine the parameters for a best-ﬁt evolutionary model, which were
used to construct maximum likelihood trees using PhyML v3.0, with
stability of the nodes assessed by bootstrap resampling at 100
iterations. NJ trees were constructed and edited using MEGA
(Kumar et al., 1994) using all isolated env sequences and reference
sequences of different subtypes obtained from the LANL HIV
sequence database (http://www.hiv.lanl.gov). Segregation among
different sequences was examined using the Slatkin–Maddison test
as implemented on MacCLade, version 4.01, and maximum compo-
site likelihood distances as calculated using MEGA. Viral diversity
was estimated as the average pairwise genetic distance using PAUP
version 4.02b2a using the previously estimated maximum likelihood
model. The divergence of each sequence from the MRCA was
calculated in DIVEIN (Deng et al., 2010). Sequence variability at each
amino acid position was determined by calculating Shannon entropyscores using the LANL Entropy-one tool (Korber et al., 1993) with
comparisons made using the two-tailed paired t-test. N-linked
glycosylation sites were predicted using the N-Glycosite tool from
the LANL database (Zhang et al., 2004). Signature amino acid
differences were identiﬁed using the VESPA program from the LANL
database, and histograms displaying the number of differences at
each site were constructed using the Microsoft Excel program.
Construction of chimeric viruses
Chimeric env sequences were constructed by swapping a
region from a R5 clone with the corresponding region from a X4
or dual-tropic env using overlapping PCR (Kirchherr et al., 2007);
speciﬁc primer sequences are available upon request. Chimeras
were conﬁrmed by sequence analysis, and the coreceptor usage of
these chimeric envelopes was determined as previously detailed
(Lin et al., 2010).
Statistical analysis
P-values were determined by 2-sided tests, with values less
than or equal to 0.05 considered signiﬁcant. All statistical tests
were performed with GraphPad Prism software version 5.0
(Graph Pad Software Inc., San Diego, CA) and Stata version 8.0
(Stata Corporation).Acknowledgments
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